Normal view

What do the proposed NDIS changes mean for people with disability living in supported accommodation?

FG Trade/Getty

Amid major reforms to the National Disability Insurance Scheme (NDIS), unveiled last week, NDIS minister Mark Butler announced the government’s plans to commission supported independent living services for people with disability, “rather than relying on a market that isn’t working”.

Supported independent living is NDIS funding for support workers who can assist people with disability who need some level of help at home all the time.

This announcement indicates a shift away from a market-based model – in which NDIS participants choose who provide services to them, and what kinds – to a more regulated, government-vetted system.

For people with the most significant and permanent disabilities, these changes – together with cuts to social and community participation funding – may be significant. Here’s how it might work.

What is supported independent living?

Supported independent living pays for support workers to help with day-to-day activities such as showering, preparing meals and doing laundry.

Supported independent living payments are often used to fund support provided in group homes. This is where a number of NDIS participants live together and one worker provides shared support to them. Some group homes may also receive another kind of NDIS payment, called specialist disability accommodation funding, which pays for purpose-built accessible housing for people with very high needs.

More than 17,000 people with disability live in group homes in Australia. Around 30% have intellectual disability. Residents frequently have high and complex support needs, and very few other people in their lives beyond support workers.

How did we get here?

Group homes are largely a result of the de-institutionalisation movement in the late 20th century, and grandfathering of supported accommodation from state disability services to the NDIS. People with disability often didn’t have a choice of where they moved to or who they lived with.

New kinds of specialist disability accommodation, such as apartment living or independent units, have been developed in recent years through the NDIS. But data shows many people are still sharing with co-residents they don’t choose, in group living they haven’t chosen.

Stories of abuse, violence and neglect in group homes, shared by residents, are harrowing.

The Disability Royal Commission recommended group homes should be phased out by 2038. But federal, state and territory governments have not yet commenced working together on this recommendation.

A 2023 inquiry also identified many issues in how supported accommodation – meaning the combination of funding for support workers and purpose-built accommodation – currently works in the NDIS.

The inquiry found a greater need for choice and control for people living in group homes (for example, about where they live), better education of the workforce, and more regulation of these living arrangements.

So, how might commissioning providers work?

We still don’t have a lot of detail. But the goal will be to create greater oversight and control over who provides services, and curb safety issues such as neglect and abuse while improving quality.

It could mean the government will purchase more low-cost accommodation where several people share a support worker. And we can expect a more restricted list of registered providers, meaning the companies the government allows to employ the support workers.

Commissioning could also mean the government introduces new rules, such as caps on the number of people with disability who live in one place. Such restrictions are currently in place for specialist disability accommodation, but not supported independent living.

In practice, this might look similar to the current makeup of group homes – mostly small-scale group living – but there will be more regulation. There is also a question about whether commissioning will improve residents’s choice about where they live, or who they live with – a basic right.

The government has also begun trials in ten rural, remote and First Nations communities where they have identified service demand for people with disability far outstrips what is available, including supported accommodation. In these cases, commissioning services will focus on understanding what specific barriers there are to accessing support, considering cultural needs and what local services are available.

Living independently is about more than accommodation

Amid last week’s reforms, the government also announced it will reduce NDIS payments to individuals for social and community participation – from around A$31,000 to $26,000 a year.

These payments fund a person’s needs to travel outside their home, so they are an important part of what it means to live independently. They may cover the cost of attending appointments, shopping or paying bills, taking part in social activities and developing life skills.

The government has instead unveiled a new $200 million Inclusive Communities Fund. This will fund community groups to “host genuine participation activities” for those with disability.

This is part of the government’s broader push to provide foundational and mainstream supports – such as community or school programs, activities, skills-building and information – for people outside of the NDIS.

In some cases, it could mean better inclusion of people with disability in the broader community, such as through local sporting clubs.

But if the NDIS funding that allows people to take part in their community and build independence is cut before these other supports are properly established, there is a risk of further isolation. This could particularly affect people with disability in group homes with the highest needs who rely on this kind of funding to leave home.

And there continue to be concerns about the potential role of algorithms in determining who will receive NDIS funding and who doesn’t.

People with disability want – and have a right – to live a life connected to people and community. This right must remain at the heart of plans to reform how and where they live.

The Conversation

Libby Callaway sits on the NDIS Evidence Advisory Committee Assistive Technology and Capital subcommittee established by the Commonwealth Government Department of Health, Disability and Ageing. She receives funding from the National Health and Medical Research Council (NHMRC), Australian Research Council (ARC), and icare NSW.

Jack Francis Kelly has previously undertaken research funded by the National Disability Insurance Agency in roles with UTS and the Council for Intellectual Disability (CID). Jack is an NDIS participant.

Phillippa Carnemolla receives funding from the Australian Research Council. She is affiliated with Melbourne Disability Institute via the Centre for Universal Design Australia.

Sally Robinson receives funding from the Australian Research Council and Federal and State Governments for research. She is affiliated with the National Disability Research Partnership.

Synthetic biology promised to rewrite life – with the death of its pioneer, J. Craig Venter, how close are scientists?

First came the Human Genome Project, then came the field of synthetic biology. Alena Butusava/iStock via Getty Images Plus

When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.

For the first time, DNA – the molecule that carries the instructions for life – had been written on a computer, assembled in a laboratory and used to control a living cell. The achievement suggested something profound: Life might not only be understood but designed.

A biologist widely recognized for his groundbreaking contributions to genomics, including leading efforts to sequence the first draft of the human genome, Venter and his team’s successful creation of the first synthetic bacterial cell is considered pivotal to the field of synthetic biology.

J. Craig Venter in a suit at a conference, looking off-camera
J. Craig Venter was a decorated scientist and entrepreneur. Mauricio Ramirez/Science History Institute via Wikimedia Commons, CC BY-SA

By combining biology and engineering, synthetic biology seeks to design and build new biological systems or redesign existing ones for useful purposes. Rather than only observing how life works, scientists use tools such as DNA synthesis and genetic engineering to “program” cells to perform specific tasks, such as producing vaccines, developing sustainable fuels or detecting environmental toxins.

But how far has the field gone since Venter’s original synthetic bacterial cell?

As a biochemist who uses genomics in my teaching and research, I am interested in understanding what this shift in biology means and how far it has actually taken scientific innovation. Following Venter’s death on April 29, 2026, it is worth revisiting that moment and asking whether synthetic biology has delivered on its promise.

What is synthetic biology?

For much of the 20th century, biology focused on decoding life.

The discovery of DNA’s structure in 1953 revealed how genetic information is stored. Decades later, the Human Genome Project that Venter helped accelerate mapped the full set of human genes.

But Venter and others pushed the field further: If DNA could be read like code, could it also be written?

This idea underpins synthetic biology, which aims to design and construct biological systems rather than simply study them. Instead of modifying one gene at a time, researchers began exploring whether entire genomes could be built and inserted into cells.

Synthetic biology offers both tantalizing promises and terrifying risks.

In 2010, Venter’s team demonstrated that this was possible. They constructed a bacterial genome and used it to take control of a living cell. While the cell itself was not built entirely from scratch, their work showed that the instructions for life could be engineered.

In other words, synthetic biologists were moving from reading life to rewriting it entirely.

Big promises and bold expectations

Synthetic biology has already led to a range of promising outcomes across medicine, energy and environmental science.

Researchers have engineered microbes to produce lifesaving drugs such as artemisinin, an antimalarial compound, and to manufacture sustainable biofuels that could reduce reliance on fossil fuels. In addition, researchers are using synthetic biology to design organisms capable of detecting and breaking down environmental pollutants, offering new tools for bioremediation.

At the heart of these ideas was a powerful analogy: If biology could be treated like software, then designing organisms might one day resemble writing code.

This vision attracted significant investment and policy attention. The U.S. Government Accountability Office has highlighted synthetic biology’s potential to address challenges in multiple industries while also raising important ethical and safety considerations. For example, synthetic biology techniques could be used to develop biological weapons and could unintentionally harm ecosystems and human health.

Progress slower than expected

Despite this progress, synthetic biology has not fully realized its early ambitions. One major reason is the complexity of living systems.

Early approaches to synthetic biology treated cells as modular systems, where components could be predictably exchanged. In practice, biological systems are highly interconnected. Gene interactions are difficult to predict, and results observed in controlled laboratory conditions do not always scale to real-world environments.

This challenge has been particularly evident in areas such as biofuels, where translating laboratory successes into industrial-scale production has proved difficult.

There are also more fundamental limitations. Scientists still cannot construct a fully living organism from nonliving components alone. Even Venter’s synthetic cell depended on an existing biological system to function.

As a result, the goal of creating life entirely from scratch remains out of reach for now.

New questions and emerging risks

As technology has advanced, it has also raised new ethical and security concerns. The same tools used to design beneficial organisms could potentially be misused.

Synthetic biology is widely recognized as a dual-use field, where advances in gene editing, DNA synthesis and bioengineering may enable not only medical and environmental innovations but also the creation or modification of harmful organisms.

The increasing accessibility of these technologies further lowers barriers to misuse, making biosecurity threats more distributed and difficult to control. At the same time, governance frameworks often struggle to keep pace with rapid technological developments, leaving gaps in oversight and international coordination.

Microscopy image of a grey spherical blob with a rough surface of spherical protuberances
This synthetic ‘minimal cell’ has been stripped of all but its most essential bacterial genes – and can still evolve. Tom Deerinck and Mark Ellisman of the National Center for Imaging and Microscopy Research at the University of California at San Diego

Beyond immediate risks, broader questions remain about how far humans should go in redesigning life and what unintended consequences such changes could have for ecosystems. Engineered organisms may introduce risks such as genetic contamination and ecosystem disruption, which would harm biodiversity and ecosystem services.

These concerns are likely to become more pressing as the technology behind synthetic biology continues to develop, particularly as emerging tools such as artificial intelligence accelerate the design of new biological systems.

Venter’s legacy

The implications of the idea that life could be engineered rather than just observed is still unfolding.

Synthetic biology has not yet delivered a world of fully programmable organisms solving global challenges. But it has changed expectations, both within science and beyond, about what might be possible in biological design.

In that sense, the impact of synthetic biology is already clear: It has altered not just how scientists study life but how society imagines its future.

Venter’s legacy includes the questions he made unavoidable: how far scientists should go in designing life, who gets to decide, and what responsibilities come with that power. The answers remain unsettled. But the trajectory seems to be that science is learning, cautiously and imperfectly, to author life.

The Conversation

André O. Hudson receives funding from the National Institutes of Health and the National Science Foundation

❌